Hyundai Marine & Fire Insurance Co., Ltd. (001450.KS) Earnings Call Transcript
February 23, 2026
Earnings Call Speaker Segments
[Interpreted] I'm [indiscernible] in charge of Investor Relations at Hyundai Marine & Fire Insurance. Thank you so much for taking time out of your busy schedules to join us here today at our 2025 fiscal year-end earnings conference call. This conference call will be conducted with consecutive interpretation in both Korean and English and is expected to last approximately 1 hour, including time for Q&A. We will begin with a presentation walking you through the 2025 financial results and a 2026 business outlook, followed by a Q&A session with our management team present here today. So without further ado, let us dive into the review of our fiscal year-end financial results and our outlook for the future.
[Interpreted] Good afternoon. I am Kyuwan Jeong, CFO and Head of the Corporate Planning and Management Group at Hyundai Marine & Fire Insurance. At the outset, I'd like to extend my deepest gratitude to the investors and analysts for joining our conference call today. I will now present our financial results for the period. Please refer to the summarized financial results on Page 3. For 2025, net income on a separate basis recorded KRW 561.1 billion, representing a 45.6% decline year-on-year. Looking at the details, our insurance service result decreased across all business lines, including commercial, long-term and auto, specifically due to the deterioration of long-term insurance performance and the automobiles segment swinging to a loss, the total insurance service result reached KRW 396.1 billion, a 62% decline compared to the previous year. Net investment income recorded KRW 330.3 billion, down 6.2%. In the fourth quarter alone, we recorded a net loss of KRW 73 billion as the deficit widened Y-o-Y. However, our new business CSM multiple reached 15.9x, an improvement of 3.1x year-on-year, driven by proactive rate hikes as well as sustained efforts to optimize our product and coverage portfolios. In Q4, the multiple recorded 15.8x, slightly lower than the previous quarter. This was primarily due to the industry-wide discontinuation of drivers insurance products in December, which possesses relatively lower multiples. Nonetheless, our multiple remained the highest in the industry. And finally, our K-ICS ratio or solvency ratio rose significantly by 33.1 percentage points to reach 190%. This achievement is attributed not only to macroeconomic factors such as rising market interest rates, but also to our internal asset liability management or ALM improvement efforts as well as successful institutional updates regarding insurance risk calculation standards. Now I will discuss our performance by business segment, focusing primarily on the Q4 results. For the full year 2025, the insurance service result for long-term insurance recorded KRW 338.1 billion, representing a 60.9% decrease year-on-year in the fourth quarter. And in the fourth quarter alone, results deteriorated by KRW 131.5 billion year-on-year. To give you a little bit of context into the reasons behind this, while CSM amortization income increased by KRW 15.3 billion Y-o-Y and the negative gap in claims experience variance remained similar to the previous year, expenses related to onerous contracts rose by KRW 146.4 billion. This increase was driven by the best estimate assumption updates, which reflected rising loss ratios and medical indemnity. And in fact, medical indemnity accounted for 90% of our total claims experience variance. Now regarding persistency, the 13-month ratio recorded 86.6%, down 0.6 percentage points, while the 25 months ratio remained on par Y-o-Y. Looking at sales, the monthly average for new businesses for long-term insurance recorded KRW 10.7 billion, a 9.8% decline from KRW 11.9 billion average in 2024. New business for health care insurance averaged KRW 9.8 billion, a 9.3% decline. Strategically, we are increasing the proportion of no lapse products, which offer higher CSM multiples while expanding the share of year-term policies to enhance our management of interest rate sensitivity. As of year-end 2025, our CSM balance stood at KRW 8.9 trillion. Despite robust inflows from new businesses, the balance declined 7.5% compared to the previous quarter, a drop from around KRW 9.2 trillion. This is due to negative experience adjustments, including the upward revision of loss ratio assumptions and the impact of the education tax rate hike. By channel, we achieved improved new business CSM multiples in both our Tied and GA channels. Moving forward, we will strengthen sales in the highly profitable tied channel while focusing on enhancing efficiency within the GA channel. Moving to the Auto and Commercial segments. In auto insurance, the cumulative effect of previous rate cuts led to an insurance service loss of KRW 90.8 billion, resulting in a swing to a deficit. Our commercial insurance service results stood at KRW 148.8 billion, a 6.1% decrease Y-o-Y. Although the frequency of large-scale claims such as the Kumho Tire and [ Eland ] fires increased in 2025, we maintained relatively solid performance by growing our retained premiums in high-quality lines. Notably, our overseas branches in Japan and the U.S., among others, are showing synchronized growth in both scale and profit and their contribution to our bottom line is steadily increasing. However, our retention rate temporarily took a dip due to a rise in reinsurance premiums following these large-scale accidents. Next, I will cover asset management. As a result of our sustained ALM efforts throughout 2025, the weight of domestic bonds in our portfolio increased to 43%, while the proportion of loans and alternative investments decreased. For the full year 2025, net investment income recorded KRW 330.3 billion. Excluding the deduction for net insurance finance expenses, investment profit slightly increased to approximately KRW 1.218 trillion. However, interest expenses rose by KRW 31.7 billion to reach KRW 880.1 billion, causing total net investment income to decline 6.2% Y-o-Y. This increase in interest expenses stems from the reclassification of the experience variance related to dividend cash flows from net income to other comprehensive income. Following the FSS's unification of accounting standard, KRW 66.4 billion was reclassified from net income to OCI at the end of Q4 2025. And consequently, our investment yield recorded 2.66%, a 15 bps decrease compared to the previous year. Now turning to our capital and solvency position. Our K-ICS ratio reached 190.1% at year-end 2025, reflecting the successful outcomes of our capital enhancement measures. Similarly, core capital ratio has maintained a steady upward trajectory after bottoming out in Q1 of last year. This improvement in our solvency metrics is primarily due to our narrowing of the duration gap achieved by increasing the weight of long-term bonds in our asset portfolio and the share of year-term products within our liabilities. Our duration gap, which stood at approximately 3.2 years in Q1 2025, improved significantly to 0.7 years by year-end. And consequently, our K-ICS sensitivity to interest rate shifts has stabilized, now reaching 4.4 percentage points per 50 bps, a marked improvement from the 11 percentage point level recorded at the end of 2024. I will now outline our key management strategies and outlook for 2026. Regarding the overall insurance landscape, we anticipate heightened interest rate volatility throughout the year. Furthermore, with the implementation of the actuarial supervision advancement plan scheduled for Q2, we expect the volatility of our best estimate liability to increase due to updates to the loss ratio and expense ratio assumptions. Conversely, there are clear positive catalysts for our bottom line, including the introduction of managed benefits, the launch and contract transition of fifth generation indemnity insurance and the regulatory reform of the auto insurance system regarding minor injuries. And in this environment, Hyundai Insurance will concentrate its main corporate resources on further strengthening our capital position and recovering our earnings generation capacity. By business segment, first and foremost, in commercial insurance, we will maintain stable earnings power by focusing on portfolio optimization within high-quality lines. Specifically, we will leverage our strengthened partnerships with Hyundai affiliates to solidify our performance in marine insurance while continuing to rebalance low-quality contracts to accelerate structural improvements. And in auto insurance, we project a performance turnaround in 2026 compared to the previous year. Driven by the base rate increase in February and the adjustment of premiums for riders, we aim to increase earned premium per policy. By combining the minor injury system reforms such as those regarding estimated future treatment costs with our internal efforts to curb rising compensation costs, we are focusing our capabilities on entering a meaningful insurance service result improvement cycle starting this year. Finally, in long-term insurance, our top priority is the sustained enhancement of new business profitability. In order to achieve this, we will continue to expand the sales mix of year-term simplified health products, which offer both robust margins as well as low interest rate sensitivity. Regarding loss ratios, we are seeing improvements in our first and second underwriting year loss ratios. We plan to maintain this trend through 2026 to steadily increase the proportion of high-quality new business within our in-force portfolio. For medical indemnity specifically, we forecast loss ratio improvements driven by the launch of the fifth generation product and the implementation of managed benefits. Supported by our concerted efforts to tighten claims review and audits, we are committed to achieving a meaningful improvement in our experience variance results this year. And next is asset management. In 2026, we will continue to refine our ALM by increasing the proportion of long-term bonds and expanding bond forward volumes to steadily increase the interest rate sensitivity of our assets. Given the recent rebound in market interest rates, we project that investment profit will increase year-on-year, driven primarily by interest income as the yields on interest-bearing assets continue to improve. Even under our strengthened ALM stance and position, we will maintain diligent in sourcing high-yield assets to further enhance our overall investment yield. And lastly, I will discuss the direction of our capital policy, its strategies and allocation plan. Leveraging our improved capital position, we will strengthen our core business competitiveness to drive profitability. For the K-ICS ratio, we aim to achieve higher Y-o-Y levels by expanding available capital and minimizing duration gap mismatches. Regarding the core capital ratio, we plan to reach the regulatory recommended level early on by managing risk amounts and improving earnings capacity based on the full recognition of surrender value reserves as core capital. Regarding shareholder returns, we plan to implement the phased cancellation of our existing treasury shares. A portion of these shares will be reviewed for use as employee performance compensation to align long-term corporate value with talent retention. However, this will be managed from a long-term perspective to minimize any shareholder dilution. Once distributable income is secured in the future, we plan to gradually expand shareholder returns through accelerated share buybacks and cancellations alongside cash dividends to resolve the current undervaluation of our stock. Ultimately, once we have sufficiently visibility regarding a sustainable return policy, we will establish and share with you and communicate our midterm corporate value plan with market. And finally, in an effort to strengthen our communication with the market, we are planning to expand our earnings conference calls to a quarterly basis starting this year. Through our proactive IR activities and communications, we will continue to enhance the transparency and timeliness of the information that we provide. This concludes my presentation on the 2025 financial results and 2026 outlook. Thank you very much.
[Operator Instructions] [Interpreted] The first question will be provided by Do Ha Kim from Hanwha Investment & Securities.
[Interpreted] I have 2 questions for you. One is on onerous contracts and the other is on CSM. Number one, we are in the position where we can compare with peers the onerous contract figures. And even if we take into consideration everything that you have explained, if we compare the 5-year moving average of before, which stood at KRW 150 billion loss, this still is a 2x increase. And to just say that this is because of 1 or 2 factors such as pediatric ratio is a little bit too much and excessive. So if you could provide any other reasons behind this big jump and variation, that would be great. And if you could also give us a little bit of color on the outlook for the figures as of the end of 2026, that would also be very helpful in terms of the 5-year moving average that you foresee. And number two, regarding the minus 1.15 variation, the adjustment that you said referring to the education rate tax cuts and the rate cuts. Could you provide a little bit more color and detail on the reasons why we reached this figure?
[Interpreted] I'm the Chief Actuary. First, I'll address your question about the onerous contracts. If you look at the figures that you referred to in terms of the onerous contracts, there was an increase of KRW 140 billion in terms of the expense, but of that, KRW 100 billion was a one-off expense. And so if you exclude the one-off expenses, the figures are on par with what you've seen before. And in terms of the expenses, you will also see KRW 150 billion in losses that was incurred from the third-generation medical indemnity. And the policyholders of this third-generation medical indemnity were previously in non-schooling age years. However, they will now be entering schooling years, which will help us forecast a decline in the loss ratio and we will even be able to see some reversals or write-backs as well. And next, regarding your question about CSM adjustments. As of the end of last year, there were adjustments made from assumption changes that amounted to about KRW 1 trillion. Of this KRW 1 trillion adjustment, about 70% stem from first and second-generation medical indemnity and 30% from simplified health insurance. And regarding the first and second-generation medical indemnity, we forecast that we will see a turn to the positive in terms of our experience variance because of the sufficient provisioning that we have done before and also as well as the implementation and introduction of managed benefits. And next, in terms of the simplified health care insurance, once the loss ratio assumption guidelines are introduced this year, the simplified health insurance loss ratio will become an issue. However, for our company, what we are doing is we have separate loss ratio assumptions for simplified health insurance. And that is why we forecast that the shock from the loss ratio assumption guidelines that will be introduced this year will have already been sufficiently absorbed within our company with the practice measures that we have implemented as well as the stringent measures that we have implemented regarding UI, which will pan through this year. I hope that answered your question.
[Interpreted] Could you also give us a little bit more detail on the one-off expense?
[Interpreted] That is something that is related to the change in the RA system before specifically when calculating the adjustment rate assumption that is included before with the renewal premium that change the ratio is now calculated by the company itself to the ratio proposed by the Supervisory Commissioner. And from our view, this is an area where we require institutional improvements and revisions, and that is why we are communicating that ask to the authorities. That is it for my answer.
[Interpreted] The following question will be presented by MW Kim from JPMorgan.
[Interpreted] So I have 2 questions for you. First, covering long-term insurance profitability and the second regarding core capital ratio. Number one, regarding long-term insurance, I would like to ask you about the long-term risk loss ratios, including IBNR. And if you could give us a little bit of color on the yearly trend that you forecast, that would also be great. Although you did give us a little bit of outlook in your presentation. If you could give us a little bit more detail on the extent of the improvements that you forecast and foresee in the next 2- to 3-year time line, that would be much appreciated. And number two, regarding the core capital ratio. On one hand, you did state in your presentation that you are committed to continue to strengthening the core capital ratio. However, as you continue to underwrite new contracts and policies, this might become a little bit of a challenge. In the past couple of years, of course, the company has managed very efficiently required capital. What is the required capital level that you forecast for this year? And also, what is the basis in terms of the new businesses that you assume when you come up with this required capital ratio?
[Interpreted] I am the Head of Long-term Insurance division. First, let me address your question about long-term insurance. First, let me address your question about the long-term insurance loss ratio, including IBNR last year was -- last year, the ratio was 101.8%, while this year was 101.2%. And on an absolute sense, if you look at those figures alone, they may seem high, but you do have to take into account the industry figures, which in terms of Hyundai Insurance, we were able to record the lowest increase in terms of the loss ratio at 1.7 per accident whereas industry-wide, the increase in loss ratio stood at from anywhere from 3.5% to 4.9%. So all in all, we have been making consider efforts and committed to managing and maintaining a healthy loss ratio, but there was a slight increase. And we believe that the inflection point for the loss ratio going down for Hyundai Insurance is this year. So this year is going to be our inflection point year. And we talked about the 0.6 percentage point in terms of the retained contract loss ratio target that we are working to achieve. And based on the efforts that we have made in January and February thus far and the results that we have seen coming from that, if we annualize that throughout the year, then we are confident that we will be able to overachieve the target that we have set. And therefore, in the next 2 to 3 years, we forecast that the loss ratio will continue on a downward trend.
[Interpreted] I am the Head of the Risk Management division. Allow me to answer your question about the core capital ratio. Of course, the difficulties in maintaining required capital related to the core capital ratio that you alluded to in your question is an area of potential concern. However, we do need to take into consideration that when we implement and when we bring in new businesses, we also make sure that we strengthen the management of the first year to third year loss ratios in terms of the first year and second year UI loss ratios in particular, and this will translate into lower insurance risk loss ratios as well. And you have seen in our performance of last year that our proportion or weight of year-term insurance increased to a maximum of 56% in our portfolio. And this is part and parcel of our efforts to make sure that we improve the interest rate sensitivity in terms of our long-term insurance portfolio. That stance is going to continue into this year with us making continued improvements in strengthening our asset liability management efforts as well as making sure that the interest rate sensitivity of our assets continues on a downward trend. And so all in all, to summarize and give you an answer to your question, in terms of the new business segment, we will continue to make sure that we strengthen our management so that we can continue to increase the CSM margin while making sure that we adhere to the capital requirements through managing our ALM at more stringent levels so that everything that we do is value-centric and value focused.
[Interpreted] The following question will be presented by [ Jay Han Bang ] from Goldman Sachs.
[Interpreted] I have 2 questions regarding your capital policy. Number one, if the surrender value reserve is 100% recognized into core capital at the end of 2027. What is the Tier 1 ratio that you expect after this change? And is there any company-wide targets that you have set internally? And second, my question regarding capital is once this change is implemented, what is the dividend that you forecast will be available for dividends?
[Interpreted] I am the Head of the Risk Management division. Allow me to answer your question on the capital policies. For the capital -- core capital, currently, the proportion of the surrender value reserves that are not recognized as core capital, if that is all recognized as core capital with the changes in the policies that will be implemented by the financial authorities, then on a before-tax basis, there will be a total of a KRW 1 trillion increase in our capital, which represents a 10 percentage point improvement as per our forecast. Once these changes are implemented and are in place, full-fledged as of March of 2027, we forecast that our core capital ratio will hit 80% or above. However, with that said, the supervisory authorities policies have not yet been finalized, which is why we are a little bit cautious in our projections. However, we will continue to manage our capital ratio so that we will be able to maintain at least a core capital ratio of 80%.
[Interpreted] I'm the Head of the Corporate Planning Division. Let me address your question about the impact of the SVR [ Solvency/Surrender Value Reserve ] in terms of the second part of your question. Now I'll tell you about the dividend that we will be able to -- that we will be able to provide. As of the end of last year, the SVR in Q2 represented a solvency of over 170% and with 80% to 90% provision and reserve, we were able to reach KRW 3.9 trillion after a KRW 100 billion drop. And with the 5.4 statutory reserves and the unrealized figures of around KRW 7 trillion -- about KRW 7 trillion, that will result in a dividend amount. And our sensitivity to the SVR reserve or provisioning is per 10 percent point, KRW 450 billion to KRW 500 billion. And so if the system is improved from the current 80% to around the 50% level, then that will result in a positive dividend amount. And to give you a little bit of an update on the improvements to the surrender value reserve systems, there have not yet been any particular movements or activities when we've talked to the financial authorities. However, if we refer to the meeting that was held with the FSC with insurers in October of last year, we were able to confirm the authorities' recognition and realization that there needs to be improvements made to the surrender value reserve system. So we do expect some changes that will be coming this year.
[Interpreted] The following question will be presented by HeeYeon Lim from Shinhan Investment & Securities.
[Interpreted] I have 2 questions for you. Number one is regarding non-medical indemnity loss ratios. With the implementation of the managed benefits, of course, the loss ratio on the medical indemnity side will see improvements. However, that could be offset with increased loss ratios on the non-medical indemnity side. So if you could give us a little bit of color on what expectations you have here, that would be much appreciated. And number two, my question is with regards to the loss ratio assumption guidelines. Of course, in the short term, regarding CSM, the loss ratio is going to be a lot better. Of course, that's a given. However, in the end, this can actually be incorporated to and be reflected in experience variance. So ultimately, it could be pretty much the same thing. So what is the ultimate goal? I'm a little bit confused on what the ultimate target and goal or objective of the guideline is. And also regarding this guideline, in the initial stages, the loss ratio is going to be a lot stronger and better. So do you believe that this will be incorporated and reflected into short-term profitability going up as well? And I'm also aware that there has been some dissonance in the industry as well on the guidelines. Some have been for, some have been against the guideline. What is Hyundai Insurance's stance? And what are your views on how to best implement these guidelines?
[Interpreted] I'm the Head of the long-term insurance products division. So let me first address your question about the non-medical indemnity and medical indemnity loss ratio trends. In 2025, if we were to look at the loss ratios for medical indemnity, we have to look at the industry as a whole. And as a whole, the loss ratio very much deteriorated in the industry with a lot of overheating in this segment overall. And as I've explained in terms of the market trends, Hyundai Insurance's loss ratio for medical indemnity was, of course, rose in tandem with the market, 1.7 percentage point increase. However, with that said, the industry average stood at around 4.3 to 5.6 percentage points. So Hyundai Insurance's increase in loss ratio was much more minimal. As we've explained in our presentation, our commitment to managing more stringently loss ratios in terms of first and second underwriting years is part and parcel of our commitment to make sure that we manage our non-medical indemnity loss ratios more meticulously as well. As a result, this year, we forecast that there will be a 1.5% to 2% increase in our loss ratio. And with the management benefit implementation and introduction, however, we forecast that there will be a 0.6% to 0.7% drop. And so all in all, our goal is to maintain the loss ratio for medical indemnity at around 1.7%, taking into account everything, and that is where our current loss ratio levels are at.
[Interpreted] I'm the Chief Actuary. Let me address the question on the loss ratios for the new riders. First of all, the principle or rule of thumb of this system is that when you don't have dispatch and there are uncertainties, always go for the conservative assumptions and principles that you would use. And the basis or objective of this system really is to make sure that we relax the competition in CSM margin so that you can protect against competition and new business. In terms of simplified health insurance, as we stated before, we calculate this separately from the comprehensive type insurance, and that has been the case since the fiscal year-end earnings and results since last year as well. And as you've said in the initial years, especially in the first 3 years, so short term, this will be incorporated into experience variance. However, it's still short term. And so this will be gradually incorporated into the experience loss ratio. And so our view is that this is not going to cause any significant distortions or raise any significant challenges or issues. And we believe that the task on hand for Hyundai Insurance is to make sure that we more stringently manage our new business loss ratio based on UI.
[Interpreted] The following question will be presented by Byung Gun Lee from DB Securities.
[Interpreted] I have 2 questions. First, on the medical indemnity side. As of the end of last year, we saw medical indemnity figures. I'm curious about the loss ratio of medical indemnity insurance for years 1, 2, 3. And number two, on the new business side, I'm curious about your CSM targets. And stemming from that, your yearly CSM targets as well as the increase that you forecast in surrender value reserves for this year.
[Interpreted] To answer your first question, I'm the Chief Actuary. If you combine the first to third medical indemnity generation, that stands at around KRW 2 trillion. And if you account for the fourth -- third and fourth generation, that's about KRW 1.2 trillion. I'll need to get back to you on the exact figures, but that's a ballpark amount.
[Interpreted] I'm the Head of the Corporate Planning division. Allow me to answer the second part of your question. On the new business side, first to answer your question about the monthly payments. For the long-term health care insurance, our target is KRW 9.8 billion and on CSM KRW 2 trillion. And the increase that we expect in surrender value reserves as of the end of the year will be around KRW 400 billion to KRW 500 billion.
[Interpreted] The following question will be presented by Mingi Jeong from Samsung Securities.
[Interpreted] My question is about the K-ICS ratio or the capital requirement. We've seen a reduction compared to the beginning of the year and also compared to the previous quarter as well. You've explained to us about the impacts of in terms of the decline in insurance risk and also the impact regarding interest rates, can you match with your ALM policies and commitments to give us a little bit more of a breakdown in terms of which is going -- what activities are going to impact what part of capital requirements?
[Interpreted] We have made a concerted effort in terms of our capital requirements and especially our solvency in order to make sure that we made a significant improvement compared to the end of 2024, which was a little bit unfortunate in terms of the results to make a great improvement in 2025. The insurance risk is inevitably going to increase with the increase in growth of new businesses. However, as we said before, we've made a concerted effort to make sure that we increase the weight of year-term type insurances in our portfolio. And that means that with the renewable -- with the renewal contracts that the liability side didn't increase as much as you would see in terms of new business growth. And also at the end of the year, the supervisory authorities actually implemented a new medical indemnity benefit calculation standard. Although our company had already been implementing a very conservative based calculation standard, with the introduction of this standard that was introduced by the supervisory authorities, our insurance risk dropped by KRW 500 billion and our solvency improved by 10 percentage points. In terms of ALM matching, if you look at our assets on our asset side, we have acquired significant amounts of bonds and forwards about KRW 3 trillion on both sides for bond spots, an increase of KRW 3 trillion also for forwards, an increase of KRW 3 trillion. So all in all, a big increase and jump in the duration of our assets with the increase of long-term bonds in our portfolio. And as a result of these efforts, the duration gap that stood at 2.3 to 2.6 years as of the beginning of 2025 went down to less than 1 year to stand at 0.7 years by the end of 2025. And this also results and translate into lower interest rate risks as well. And these efforts in terms of the asset side and liability side in order to increase the duration gap will continue on into 2026. That's it for me. Thank you very much.
[Interpreted] Okay. If there are no further questions, we will now proceed to questions submitted in advance via our website. We will be excluding the items that have already been addressed and covered during the Q&A session thus far, and our management team present here today will directly respond to any primary matters of interest. We did receive questions in advance from numerous individual shareholders, and we express our gratitude for the interest. We've covered most of the questions that were submitted. However, 3 shareholders submitted questions regarding IFRS framework and our plans to reduce the volatility of results under this new framework. So allow me to address this question. Since the implementation of IFRS 17, financial and earnings volatility has been higher than we had initially expected. And this has been due to a series of actuarial assumption guidelines issued by the authorities as well as the widening experience variance losses in medical indemnity. Our fundamental strategy to address this is to increase CSM amortization income, which is the primary driver of our profit by continuously refining our products and coverage wider portfolios to maintain a high new business CSM multiple. At the same time, we will be even more stringent in managing the weight of medical indemnity as well as ultra-long duration products, both of which tend to heighten earnings and financial volatility. To achieve this, we are driving new business growth centered on simplified health insurance products, which offer robust margins and relatively lower volatility, while at the same time, expanding the share of near-term and renewal type insurance products. Furthermore, to manage the volatility of experience variance within our in-force portfolio, we will further strengthen our long-term claims review process and continue to pursue efficiency in operating and business expenses. And we will stay committed to communicating and being transparent with our shareholders. Thank you very much for your attention.
[Interpreted] This concludes our earnings call. For any additional inquiries, please feel free to contact our IR team at any time. A very big thank you to all the investors and analysts for joining us today. [Portions of this transcript that are marked [Interpreted] were spoken by an interpreter present on the live call.]
Read the full transcript via the API
You're viewing the first half of this call. Get the complete Hyundai Marine & Fire Insurance Co., Ltd. transcript - plus 252,000+ transcripts from 12,000+ companies, speaker segments and full-text search - through the EarningsAPI REST API or hosted MCP server.
Get an API key View API docs →For developers and AI pipelines
Programmatic access to Hyundai Marine & Fire Insurance Co., Ltd. earnings transcripts and 252,000+ others is available through the
EarningsAPI REST API and the hosted MCP server.
Quarterly plans from $105 - full transcripts, speaker segments, full-text search,
and the /api/v1/transcripts/recent polling endpoint for ETL pipelines.